Muneer A. Satter, Director, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), bought 60,000 shares at $2.02 ($121K) on 2018-12-13, disclosed to the SEC on 2018-12-14.
Open-market purchase of $121k ARPO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 20,000 | $41K | 33.8% |
| 2 | $2.02 | 20,000 | $40K | 33.3% |
| 3 | $2.00 | 20,000 | $40K | 32.9% |
| Total | $2.02 avg | 60,000 | $121K | 100% |
| Filing → |
| ANNX | BUY | 2025-11-19 | $5.1M | — | Filing → |
| ANNX | BUY | 2023-12-28 | $1.0M | — | Filing → |
| ANNX | BUY | 2023-02-14 | $36.0M | — | Filing → |